Loading…
Loading…
Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.
June has been a month full of excitement in the ETF market. While commercial space and AI infrastructure attracted a significant amount of investor attention, biotechnology exposure comprises four out of the five top-performing equity ETFs as of June 29.
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- KraneShares today announced that its China ETF, the KraneShares China Technology & Semiconductor STAR 50 Index ETF (NYSE: KSTR)*, returned +71.70% year-to-date (YTD) and +131.80% over the past year as of June 30th, 2026.1
KSTR climbs to a fresh 52-week high amid rising optimism that improving U.S.-China relations could lift the Chinese tech stocks.
KraneShares SSE Star Market 50 Index ETF (NYSEARCA:KSTR - Get Free Report)'s stock price traded up 0.8% during trading on Monday. The company traded as high as $19.57 and last traded at $19.53. 78,487 shares changed hands during trading, a decline of 19% from the average session volume of 96,318 shares. The stock had
As Trump and Xi are expected to meet at the APEC Summit, optimism grows for Asia-Pacific Emerging ETFs poised to gain from a U.S.-China trade thaw.
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cambricon Technologies Corporation Limited (“Cambricon”), often described as “China's answer to Nvidia1,” has been one of the standout performers on Shanghai's Science & Technology Innovation Board (“STAR Market”) in 2025.
Earlier this month, the Nasdaq announced rule changes in regards to how small China companies go public in the United States. Once these rules are set into stone, China-based companies will now need at least $25 million to list on the exchange.
SEC filings for KSTR aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.